Background As the number and type of cancer treatments available rises and patients live
with the consequences of their disease and treatments for longer, understanding …

ClinicoEconomics and Outcomes Research, Current Medical Research and Opinion, Expert
Review in Pharmacoeconomics and Outcomes Research, Journal of Medical Economics …

Aims To understand patient preferences for once‐daily oral versus once‐weekly injectable
type 2 diabetes mellitus (T2DM) medication administration profiles, and reasons for their …

Introduction Gene therapy has shown promise in clinical trials for patients with haemophilia,
but patient preference studies have focused on factor replacement treatments. Aim We …

Objective To quantify preferences for preventive therapies for rheumatoid arthritis (RA)
across three countries. Methods A web-based survey including a discrete choice experiment …

Objectives To quantify tolerance to risks of preventive treatments among first-degree
relatives (FDRs) of patients with rheumatoid arthritis (RA). Methods Preventive treatments for …

Background This review aimed to 1) identify and assess the quality of discrete choice
experiments (DCEs) examining preferences related to epilepsy treatment; 2) summarize the …

Background Benefit–risk assessments for medicinal products and devices have advanced
significantly over the past decade. The purpose of this study was to characterize the extent to …

There has been intense research focus on the biological mechanisms underlying the
transition from health to disease for rheumatoid arthritis (RA) over recent years, and it is now …

Participatory value evaluation (PVE) has recently been introduced in the field of health as a
new method to elicit stated preferences for public policies. PVE is a method in which …